US Stock MarketDetailed Quotes

PHAR Pharming Group

Watchlist
  • 7.760
  • +0.080+1.04%
Close Nov 21 16:00 ET
  • 7.760
  • 0.0000.00%
Post 20:01 ET
526.40MMarket Cap-28740P/E (TTM)

About Pharming Group Company

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST?, Joenja?, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.

Company Profile

SymbolPHAR
Company NamePharming Group
Issue Price19.19
Founded2019
CEODr. Sijmen de Vries, M.D.
MarketNASDAQ
Employees382
Securities TypeDR
ADS Ratio1.0 : 10.0
Fiscal Year Ends12-31
AddressDarwinweg 24
CityLeiden
ProvinceZuid-Holland
CountryNetherlands (the)
Zip Code2333 CR
Phone31-71-524-74-00
Websitehttp://www.pharming.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Sijmen de Vries, M.D.
  • Chief Executive Officer and Director
  • 2.81M
  • Stephen Toor
  • Chief Commercial Officer
  • --
  • Anurag Relan
  • Chief Medical Officer
  • --
  • Ruud van Outersterp
  • Chief Ethics and Compliance Officer
  • --
  • Dr. Alexander Breidenbach, PhD
  • Chief Business Officer
  • --
  • Mireille Sanders, M. Sc.
  • Chief Operations Officer
  • --
  • Jeroen Wakkerman
  • Chief Financial Officer
  • --
  • Deborah A. Jorn, M.B.A.
  • Vice Chairman of the Board
  • 87.00K
  • Steven Baert
  • Director
  • 90.00K
  • Barbara Yanni
  • Director
  • 94.00K
  • Dr. Mark J. Pykett,PhD,V.M.D.
  • Director
  • 87.00K
  • Leonard Kruimer
  • Independent Director
  • 90.00K
  • Jabine van der Meijs
  • Independent Director
  • 94.00K
  • Dr. Richard Peters, M.D.,PhD
  • Chiarman of the Board
  • 46.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data